Download presentation
Presentation is loading. Please wait.
1
Volume 64, Issue 3, Pages 1027-1034 (September 2003)
Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy Rene C. Bakker, Adrianus A.M.J. Hollander, Marko J.K. Mallat, Jan A. Bruijn, Leendert C. Paul, Johan W. de Fijter Kidney International Volume 64, Issue 3, Pages (September 2003) DOI: /j x Copyright © 2003 International Society of Nephrology Terms and Conditions
2
Figure 1 Patient survival.
Kidney International , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions
3
Figure 2 Graft survival censored for death with a functioning graft.
Kidney International , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions
4
Figure 3 Graft survival censored for death with a functioning graft of the patients that stayed on the drug to which they were initially assigned. Vertical dashed lines indicate the start of the study 3months' post-transplantation (left lines), and the start of the period of survival benefit in the azathioprine arm of the study 2years' post-transplantation (right lines). Kidney International , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions
5
Figure 4 Cumulative incidence of chronic allograft nephropathy (CAN).
Kidney International , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.